Tom So

The FDA has continually slow-walked the approval of rapid tests for development. The Trump administration was utterly uninterested in any COVID policy outside the vaccines.

In little more than a decade, machine learning has moved from a highly specialized technique to something that almost anyone with data and computational power can do. That is to be welcomed — yet it remains essential that the industry can navigate both the proliferation of tools and frameworks in the space and the ethical issues that are becoming